Market Research Logo

Global Medical Marijuana Market 2017-2027

Global Medical Marijuana Market 2017-2027

The global medical marijuana market was valued at $12bn in 2016 and is projected to grow at a CAGR of 18% in the first half of the forecast period. The market is dominated by the Chronic Pain submarket which held 40% share of that market in 2016.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 120-page report you will receive 87 charts – all unavailable elsewhere.

The 120-page report provides clear detailed insight into the global medical marijuana market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Medical Marijuana Market forecasts from 2017-2027
  • Revenue forecast for the medical marijuana market by Application:
  • Chronic Pain
  • Arthritis
  • Migraine
  • Cancer
  • Others
Each submarket is further divided by region: North America, Europe, RoW
  • This report provides individual revenue forecasts to 2027 for these regional and national medical marijuana markets:
  • North America:
  • USA
  • Canada
  • Europe:
  • Belgium
  • Croatia
  • Finland
  • France
  • Italy
  • Rest of Europe
  • RoW:
  • Israel
  • Australia
  • Other Countries
  • This report discusses the leading companies in the global medical marijuana market:
  • Cara Therapeutics, Inc.
  • Cannabis Sativa, Inc.
  • CannaGrow Holdings, Inc.
  • Aphios Corporation
  • United Cannabis Corporation
  • Growblox Sciences, Inc.
  • GreenGro Technologies, Inc.
  • GW Pharmaceutical, PLC.
  • International Consolidated Companies, Inc.
  • Lexaria Biosciences Corp.
  • This report also listed 84 other companies involved in medical marijuana production, including their reported revenues (when available) and number of employees
  • This report provides a patent analysis table for medical marijuana
  • This report discusses the drivers, restraints as well as porter’s five forces analysis of the global medical marijuana market
Visiongain’s study is intended for anyone requiring commercial analyses for the global medical marijuana market. You find data, trends and predictions.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.


1. Report Overview
1.1 Global Medical Marijuana Market Overview
1.2 Research Methodology
1.2.1 Primary Research
1.2.2 Secondary Research
1.3 Market Evaluation & Forecasting Methodology
1.4 Global Medical Marijuana Market Segmentation
1.5 Overview of Findings
1.6 Why You Should Read This Report
1.7 How This Report Delivers?
1.8 Key Questions Answered by This Analytical Report
1.9 Frequently Asked Questions (FAQ)
1.10 Who is This Report For?
1.11 Associated Visiongain Reports
1.12 About Visiongain
2. Introduction to Medical Marijuana Market
3. Global Medical Marijuana Market Forecast 2017-2027
3.1 Market Breakdown by Application, 2017-2027
3.2 Market Breakdown by Geography, 2017-2027
4. Global Medical Marijuana Market by Application: Market Forecast 2017-2027
4.1 Overview
4.2 Chronic Pain
4.3 Arthritis
4.4 Migraine
4.5 Cancer
4.6 Others
5. Leading National Market, 2017-2027
5.1 Geographical Breakdown of the Global Medical Marijuana Market
5.2 Overview
5.2.1 North America Medical Marijuana Market Forecast, 2017-2027
5.2.1.1 USA Medical Marijuana Market Forecast, 2017-2027
5.2.1.2 Canada Medical Marijuana Market Forecast, 2017-2027
5.2.2 European Medical Marijuana Market Forecast, 2017-2027
5.2.2.1 Belgium Medical Marijuana Market Forecast, 2017-2027
5.2.2.2 Croatia Medical Marijuana Market Forecast, 2017-2027
5.2.2.3 Finland Medical Marijuana Market Forecast, 2017-2027
5.2.2.4 France Medical Marijuana Market Forecast, 2017-2027
5.2.2.5 Italy Medical Marijuana Market Forecast, 2017-2027
5.2.2.6 Rest of Europe Marijuana Market Forecast, 2017-2027
5.2.3 RoW Medical Marijuana Market Forecast, 2017-2027
5.2.3.1 Israel Medical Marijuana Market Forecast, 2017-2027
5.2.3.2 Australia Medical Marijuana Market Forecast, 2017-2027
5.2.3.3 Other Countries Marijuana Market Forecast, 2017-2027
6. Global Medical Marijuana Market, Qualitative Analysis, 2017-2027
6.1 Porter’s Five Forces Analysis of the Medical Marijuana Market 2017-2027
6.1.1 Bargaining Power of Buyers (Low)
6.1.2 Bargaining Power of Suppliers (High)
6.1.3 Threat of New Entrants (Low)
6.1.4 Threat of Substitute Products (High)
6.1.5 Intensity of Competitive Rivalry (High)
6.2 Drivers & Restraints
6.2.1 Increasing Prevalence of Cancer
6.2.2 Increasing Research in Medical Marijuana
6.2.3 Growing Number of Mergers and Acquisitions
6.2.4 Increasing Funding for Cancer Research by Governmental Organisations
6.2.5 Increasing Investment from Government, Public and Private Sector
6.2.6 Increased Focus towards Advanced Treatment Protocols
6.2.7 Increased Awareness to Reduce Healthcare Costs
6.2.8 Opportunities in Emerging Economies
6.3 Patent Analysis
7. Leading Companies in Medical Marijuana Market
7.1 Cara Therapeutics, Inc.
7.1.1 Cara Therapeutics, Inc.: Company Overview
7.1.2 Cara Therapeutics, Inc.: Product Portfolio
7.2 Cannabis Sativa, Inc.
7.2.1 Cannabis Sativa, Inc.: Company Overview
7.2.2 Cannabis Sativa, Inc.: Recent Developments
7.3 CannaGrow Holdings Inc.
7.3.1 CannaGrow Holdings Inc.: Company Overview
7.4 Aphios Corporation
7.4.1 Aphios Corporation: Company Overview
7.4.2 Aphios Corporation: Product Portfolio
7.4.3 Aphios Corporation: Recent Developments
7.5 United Cannabis Corporation
7.5.1 United Cannabis Corporation: Company Overview
7.5.2 United Cannabis Corporation: Recent Developments
7.6 Growblox Sciences, Inc.
7.6.1 Growblox Sciences, Inc.: Company Overview
7.6.2 Growblox Sciences, Inc.: Recent Developments
7.7 GreenGro Technologies, Inc.
7.7.1 GreenGro Technologies, Inc.: Company Overview
7.7.2 GreenGro Technologies, Inc.: Product Portfolio
7.7.3 GreenGro Technologies, Inc.: Recent Developments
7.8 GW Pharmaceuticals, PLC.
7.8.1 GW Pharmaceuticals, PLC.: Company Overview
7.8.2 GW Pharmaceuticals, PLC.: Product Portfolio
7.8.3 GW Pharmaceuticals, PLC.: Recent Developments
7.9 International Consolidated Companies, Inc.
7.9.1 International Consolidated Companies, Inc.: Company Overview
7.10 Lexaria Bioscience Corp.
7.10.1 Lexaria Bioscience Corp.: Company Overview
7.11 Companies involved in Medical Marijuana Production
8. Conclusions
8.1 Current Leading Segments
8.2 Leading Regional Markets
8.3 Emerging Markets
8.4 The Future of the Market?
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form
List of Tables
Table 3.1. Global Medical Marijuana Market Forecast ($bn, AGR%, CAGR%) 2017-2027
Table 4.1. Global Medical Marijuana Market Forecast, by Application ($bn, AGR%, CAGR%) 2017-2027
Table 4.2. Global Medical Marijuana Market For Chronic Pain ,Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 4.3. Global Chronic Pain for Medical Marijuana Market Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
Table 4.4. Global Arthritis for Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 4.5. Global Medical Marijuana Market For Arthritis, Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027
Table 4.6. Global Medical Marijuana Market For Migraine Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 4.7. Global Medical Marijuana Market For Migraine Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027
Table 4.8. Global Medical Marijuana Market For Cancer Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027
Table 4.9. Global Medical Marijuana Market For Cancer Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027
Table 4.10. Global Medical Marijuana Market For Other Forecast ($bn, AGR%, CAGR%) 2017-2027
Table 4.11. Global Other Medical Marijuana Market Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027
Table 5.1. Global Medical Marijuana Market Forecast, by Geography ($bn, AGR%, CAGR%) 2017-2027
Table 5.2. North America Medical Marijuana Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
Table 5.3. USA Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 5.4. Canada Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 5.5. European Medical Marijuana Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
Table 5.6. Belgium Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 5.7. Croatia Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 5.8. Finland Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 5.9. France Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 5.10. Italy Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 5.11. Rest of Europe Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 5.12. Rest of World Medical Marijuana Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
Table 5.13. Israel Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 5.14. Australia Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 5.15. Other Countries Medical Marijuana Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
Table 6.1. Worldwide Estimated Incidence and Prevalence of all Cancer Types, (2012)
Table 6.2. Patent Analysis for Medical Marijuana
Table 7.1. Cara Therapeutics, Inc.: Company Overview
Table 7.2. Cara Therapeutics, Inc.: Product Portfolio
Table 7.3. Cannabis Sativa, Inc.: Company Overview
Table 7.4. Cannabis Sativa, Inc.: Recent Developments
Table 7.5. CannaGrow Holdings Inc.: Company Overview
Table 7.6. Aphios Corporation: Company Overview
Table 7.7. Aphios Corporation: Product Portfolio
Table 7.8. Aphios Corporation.: Recent Developments
Table 7.9. United Cannabis Corporation: Company Overview
Table 7.10. United Cannabis Corporation.: Recent Developments
Table 7.11. Growblox Sciences, Inc.: Company Overview
Table 7.12. Growblox Sciences, Inc.: Recent Developments
Table 7.13. GreenGro Technologies, Inc.: Company Overview
Table 7.14. GreenGro Technologies, Inc.: Product Portfolio
Table 7.15. GreenGro Technologies, Inc.: Recent Developments
Table 7.16. GW Pharmaceuticals, PLC.: Company Overview
Table 7.17. GW Pharmaceuticals, PLC.: Product Portfolio
Table 7.18. GW Pharmaceuticals, PLC.: Recent Developments
Table 7.19. International Consolidated Companies, Inc.: Company Overview
Table 7.20. Lexaria bioscience Corp.: Company Overview
Table 7.21. Other Companies Involved in Medical Marijuana Production
List of Figures
Figure 3.1. Global Medical Marijuana Market, by Application, ($bn), 2017-2027
Figure 3.2. Global Medical Marijuana Market, by Geography, ($bn), 2017-2027
Figure 4.1. Global Medical Marijuana Market, by Application, Market Share (%), 2016
Figure 4.2. Global Medical Marijuana Market, by Application, Forecast ($bn) 2017-2027
Figure 4.3. Global Chronic Pain for Medical Marijuana Market Forecast, by Geography, ($bn) 2017-2027
Figure 4.4. Global Medical Marijuana Market for Arthritis Forecast, by Geography, ($bn) 2017-2027
Figure 4.5. Global Medical Marijuana Market for Migraine Forecast, by Geography, ($bn) 2017-2027
Figure 4.6. Global Medical Marijuana Market for Cancer Forecast, by Geography, ($bn) 2017-2027
Figure 4.7. Global Other Medical Marijuana Market Forecast, by Geography, ($bn) 2017-2027
Figure 5.1. Global Medical Marijuana Market Forecast, by Geography ($bn) 2017-2027
Figure 5.2. Global Medical Marijuana Market Forecast, by Geography, Market Share (%), 2016
Figure 5.3. North America Medical Marijuana Market Forecast, by Country ($bn) 2017-2027
Figure 5.4. North America Medical Marijuana Market, by Country, Market Share (%), 2017
Figure 5.5. USA Medical Marijuana Market Forecast ($bn) 2017-2027
Figure 5.6. Medical Marijuana Market Forecast ($bn) 2017-2027
Figure 5.7. Europe Medical Marijuana Market Forecast, by Country ($bn) 2017-2027
Figure 5.8. Europe Medical Marijuana Market, by Country, Market Share (%), 2017
Figure 5.9. Belgium Medical Marijuana Market Forecast ($bn) 2017-2027
Figure 5.10. Croatia Medical Marijuana Market Forecast ($bn) 2017-2027
Figure 5.11. Finland Medical Marijuana Market Forecast ($bn) 2017-2027
Figure 5.12. France Medical Marijuana Market Forecast ($bn) 2017-2027
Figure 5.13. Italy Medical Marijuana Market Forecast ($bn) 2017-2027
Figure 5.14. Rest of Europe Medical Marijuana Market Forecast ($bn) 2017-2027
Figure 5.15. Rest of World Medical Marijuana Market Forecast, by Country ($bn) 2017-2027
Figure 5.16. Rest of World Medical Marijuana Market, by Country, Market Share (%), 2016
Figure 5.17. Israel Medical Marijuana Market Forecast ($m) 2017-2027
Figure 5.18. Australia Medical Marijuana Market Forecast ($bn) 2017-2027
Figure 5.19. Other Countries Medical Marijuana Market Forecast ($bn) 2017-2027
Figure 6.1. Porter’s Five Forces Analysis of the Medical Marijuana Market
Figure 7.1. Cara Therapeutics, Inc., Revenue, ($m), 2012-2016
Figure 7.2. Cannabis Sativa, Inc., Revenue, ($m), 2014-2016
Figure 7.3. GreenGro Technologies, Inc., Revenue, ($m), 2014-2015
Figure 7.4. GW Pharmaceuticals, PLC. Revenue, ($m), 2012-2016
Figure 7.5. GW Pharmaceuticals, PLC. Geographical Presence Share (%), 2016
Figure 7.6. Lexaria Corp., Revenue, ($m), 2012-2016
Figure 8.1. World Medical marijuana, by Application, ($bn), 2016-2027

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report